The U.S. Department of Justice has reached a settlement with Amgen over alleged kickback payments tied to its anemia drug. It was reported that the biotech drug maker will pay $24.9 million... Read more
U.S. health officials have been reviewing a higher rate of deaths among patients treated with Eprex, a Johnson & Johnson anemia drug, in a German study of stroke patients. Sixteen perce... Read more
The Food and Drug Administration has ordered Amgen to change the labels for its flagship anemia drugs in a way that could further restrict its use in treating patients with cancer. This move... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.